Manufacturer record
Crescent Therapeutics Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Crescent Therapeutics Limited (Himachal Pradesh) was declared Not of Standard Quality in June 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 78TML18002, TELMISARTAN TABLETS IP 40 MG (TELMIRAL 40) (exp Jun 2020). CDTL Chennai (CDSCO lab) found it not of standard quality: Test for Dissolution. Listed in the June 2019 alert.
Records by type
1 record linked to Crescent Therapeutics Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| TELMISARTAN TABLETS IP 40 MG (TELMIRAL 40) | Batch 78TML18002Mfg Nov 2018 · Exp Jun 2020 | Test for DissolutionDissolution | CDTL ChennaiCDSCO lab | Jun 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.